Abstract
Unique biochemical and physical challenges to both mother and fetus are observed during human pregnancy, and the placenta plays an important role in protecting the fetus and supporting its development. Consequently, many pregnancy complications are associated with altered placental biochemistry and structure. Here we have further developed a combination of analytical tools for determining the tissue metabolome of placental tissue by applying a methanol/water/chloroform extraction method followed by analysis of the polar fraction (methanol/water) using GC–ToF–MS and of the non-polar fraction (chloroform) using UPLC–LTQ–Orbitrap–MS. This combination maximises the number of different metabolites detected and is the first holistic investigation of placental tissue applying UPLC–MS. Placental tissue differs between early and late first trimester pregnancies in that the developing placenta is exposed to significantly different oxygen tensions and undergoes a change from histiotrophic to haemotrophic nutrition. Application of these metabolomic methods detected 156 unique and chemically identified metabolites that showed statistically significant differences (P < 0.05). These included changes in di- and triglycerides, phospholipids, sphingolipids, fatty acids and fatty acid carnitines. This is the first metabolomics study to identify these changes that potentially show the initiation or switch to fatty acid beta-oxidation for mitochondrial ATP production. A separate study showed a small number of changes that were related to the position of sampling of the placental tissue and to the type of delivery from pregnancy. This result indicates that variations associated with sampling position and delivery type are small compared to between-subject variation. However, the authors recommend robust experimental design which may include sampling from the same position of the placenta and from the same delivery type. When comparing tissue from term-uncomplicated pregnancies with those exhibiting preeclampsia at term, 86 unique and chemically identified metabolites showed statistically significant differences (P < 0.05). Potential changes in metabolism operating in the mitochondria, in vitamin D metabolism and in oxidative and nitrative stress were observed. These proof-of-principle studies demonstrate the sensitivity of placental tissue metabolomics to define changes related to alterations in environment and perfusion and related to diseases of pregnancy including preeclampsia. Data are available on request.
Similar content being viewed by others
References
Allen, J., Davey, H. M., Broadhurst, D., Heald, J. K., Rowland, J. J., Oliver, S. G., et al. (2003). High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nature Biotechnology, 21, 692–696.
Altun, Z. S., Uysal, S., Guner, G., Yilmaz, O., & Posaci, C. (2008). Effects of oral l-arginine supplementation on blood pressure and asymmetric dimethylarginine in stress-induced preeclamptic rats. Cell Biochemistry and Function, 26, 648–653.
Anderson, C. M. (2007). Preeclampsia: Exposing future cardiovascular risk in mothers and their children. Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing, 36, 3–8.
Atherton, H. J., Gulston, M. K., Bailey, N. J., Cheng, K. K., Zhang, W., Clarke, K., et al. (2009). Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse. Molecular Systems Biology, 5, 259.
Begley, P., Francis-McIntyre, S., Dunn, W. B., Broadhurst, D. I., Halsall, A., Tseng, A., et al. (2009). Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale nontargeted metabolomic studies of human serum. Analytical Chemistry, 81, 7038–7046.
Brison, D. R., Hollywood, K., Arnesen, R., & Goodacre, R. (2007). Predicting human embryo viability: the road to non-invasive analysis of the secretome using metabolic footprinting. Reproductive Biomedicine Online, 15, 296–302.
Broadhurst, D. I., & Kell, D. B. (2006). Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics, 2, 171–196.
Brown, M., Dunn, W. B., Dobson, P., Patel, Y., Winder, C. L., Francis-McIntyre, S., et al. (2009). Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst, 134, 1322–1332.
Brown, M., Wedge, D. C., Goodacre, R., Kell, D. B., Baker, P. N., Kenny, L.C, et al. (2011) Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics 27, 1108–1112.
Burton, G. J., Jauniaux, E., & Charnock-Jones, D. S. (2010). The influence of the intrauterine environment on human placental development. International Journal of Developmental Biology, 54, 303–311.
Cetin, I., Marconi, A. M., Bozzetti, P., Sereni, L. P., Corbetta, C., Pardi, G., et al. (1988). Umbilical amino acid concentrations in appropriate and small for gestational age infants: a biochemical difference present in utero. American Journal of Obstetrics and Gynecology, 158, 120–126.
Colombini, M. (2010). Ceramide channels and their role in mitochondria-mediated apoptosis. Biochimica Et Biophysica Acta-Bioenergetics, 1797, 1239–1244.
Davey, D. A., & Macgillivray, I. (1988). The classification and definition of the hypertensive disorders of pregnancy. American Journal of Obstetrics and Gynecology, 158, 892–898.
Deepinder, F., Chowdary, H. T., & Agarwal, A. (2007). Role of metabolomic analysis of biomarkers in the management of male infertility. Expert Review of Molecular Diagnostics, 7, 351–358.
Dordevic, N. Z., Babic, G. M., Markovic, S. D., Ognjanovic, B. I., Stajn, A. S., Zikic, R. V., et al. (2008). Oxidative stress and changes in antioxidative defense system in erythrocytes of preeclampsia in women. Reproductive Toxicology, 25, 213–218.
Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., & Griffin, J. L. (2011a). Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chemical Society Reviews, 40, 387–426.
Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Halsall, A., McIntyre, S., et al. (2011b). Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols, 6, 1060–1083.
Dunn, W. B., Broadhurst, D., Brown, M., Baker, P. N., Redman, C. W. G., Kenny, L. C., et al. (2008). Metabolic profiling of serum using ultra performance liquid chromatography and the LTQ-orbitrap mass spectrometry system. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 871, 288–298.
Dunn, W. B., Brown, M., Worton, S. A., Crocker, I. P., Broadhurst, D., Horgan, R., et al. (2009). Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia. Placenta, 30, 974–980.
Gardosi, J., Chang, A., Kalyan, B., Sahota, D., & Symonds, E. M. (1992). Customised antenatal growth charts. Lancet, 339, 286–287.
Genbacev, O., Joslin, R., Damsky, C. H., Polliotti, B. M., & Fisher, S. J. (1996). Hypoxia alters early gestation human cytotrophoblast differentiation invasion in vitro and models the placental defects that occur in preeclampsia. Journal of Clinical Investigation, 97, 540–550.
Graca, G., Duarte, I. F., Barros, A. S., Goodfellow, B. J., Diaz, S., Carreira, I. M., et al. (2009). H-1 NMR based metabonomics of human amniotic fluid for the metabolic characterization of fetus malformations. Journal of Proteome Research, 8, 4144–4150.
Graca, G., Duarte, I. F., Barros, A. S., Goodfellow, B. J., Diaz, S. O., Pinto, J., et al. (2010). Impact of prenatal disorders on the metabolic profile of second trimester amniotic fluid: a nuclear magnetic resonance metabonomic study. Journal of Proteome Research, 9, 6016–6024.
Graca, G., Duarte, I. F., Goodfellow, B. J., Barros, A. S., Carreira, I. M., Couceiro, A. B., et al. (2007). Potential of NMR spectroscopy for the study of human amniotic fluid. Analytical Chemistry, 79, 8367–8375.
Granger, J. P., Alexander, B. T., Llinas, M. T., Bennett, W. A., & Khalil, R. A. (2002). Pathophysiology of preeclampsia: Linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation, 9, 147–160.
Guilbert, J. J. (2003). The world health report 2002—reducing risks, promoting healthy life. Educ Health (Abingdon), 16, 230.
Gupta, R., Maruthy, K. N., Mhaskar, A. M., & Padmanabhan, L. D. (2003). Serum nitrate levels as an index of endothelial function in pre-eclampsia and normal pregnancy. Indian Journal of Physiology and Pharmacology, 47, 185–190.
Haugen, M., Brantsaeter, A. L., Trogstad, L., Alexander, J., Roth, C., Magnus, P., et al. (2009). Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology, 20, 720–726.
Heazell, A. E. P., Brown, M., Dunn, W. B., Worton, S. A., Crocker, I. P., Baker, P. N., et al. (2008). Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers. Placenta, 29, 691–698.
Heazell, A. E. P., Brown, M., Worton, S. A., & Dunn, W. B. (2011). Review: The effects of oxygen on normal and pre-eclamptic placental tissue—insights from metabolomics. Placenta, 79, 413–424.
Horgan, R. P., Broadhurst, D. I., Dunn, W. B., Brown, M., Heazell, A. E., Kell, D. B., et al. (2009a). Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies. Placenta, 31, 893–901.
Horgan, R. P., Clancy, O. H., Myers, J. E., & Baker, P. N. (2009b). An overview of proteomic and metabolomic technologies and their application to pregnancy research. Bjog-an International Journal of Obstetrics and Gynaecology, 116, 173–181.
Jauniaux, E., Watson, A. L., Hempstock, J., Bao, Y. P., Skepper, J. N., & Burton, G. J. (2000). Onset of maternal arterial blood flow and placental oxidative stress—a possible factor in human early pregnancy failure. American Journal of Pathology, 157, 2111–2122.
Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) Metabolomics: A global biochemical approach to drug response and disease, Annual Review of Pharmacology and Toxicology, 653–683.
Kaneko-Tarui, T., Zhang, L., Austin, K. J., Henkes, L. E., Johnson, J., Hansen, T. R., et al. (2007). Maternal and embryonic control of uterine sphingolipid-metabolizing enzymes during murine embryo implantation. Biology of Reproduction, 77, 658–665.
Kell, D. B. (2009). Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Medical Genomics 2.
Kell, D. B. (2010). Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples. Archives of Toxicology, 84, 825–889.
Kell, D. B., Brown, M., Davey, H. M., Dunn, W. B., Spasic, I., & Oliver, S. G. (2005). Metabolic footprinting and systems biology: The medium is the message. Nature Reviews. Microbiology, 3, 557–565.
Kell, D. B., & Westerhoff, H. V. (1986). Metabolic control theory: its role in microbiology and biotechnology. FEMS Microbiology Reviews, 39, 305–320.
Kenny, L. C., Broadhurst, D., Brown, M., Dunn, W. B., Redman, C. W., Kell, D. B., et al. (2008). Detection and identification of novel metabolomic biomarkers in preeclampsia. Reprod Sci, 15, 591–597.
Kenny, L. C., Broadhurst, D. I., Dunn, W., Brown, M., North, R. A., McCowan, L., et al. (2010). Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension, 56, 741–749.
Kopka, J., Schauer, N., Krueger, S., Birkemeyer, C., Usadel, B., Bergmuller, E., et al. (2005). GMD@CSB.DB: the Golm metabolome database. Bioinformatics, 21, 1635–1638.
Kossenjans, W., Eis, A., Sahay, R., Brockman, D., & Myatt, L. (2000). Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol, 278, H1311–H1319.
Mizugishi, K., Li, C. L., Olivera, A., Bielawski, J., Bielawska, A., Deng, C. X., et al. (2007). Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice. Journal of Clinical Investigation, 117, 2993–3006.
Myatt, L. (2010). Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta, 31, S66–S69.
Neilson, J. P., Lavender, T., Quenby, S., & Wray, S. (2003). Obstructed labour. British Medical Bulletin, 67, 191–204.
Page, K. (1993). The physiology of the human placenta (1st ed.). London: Routledge.
Palmer, S. K., Moore, L. G., Young, D. A., Cregger, B., Berman, J. C., & Zamudio, S. (1999). Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. American Journal of Obstetrics and Gynecology, 180, 1161–1168.
Rajakumar, A., Whitelock, K. A., Weissfeld, L. A., Daftary, A. R., Markovic, N., & Conrad, K. P. (2001). Selective overexpression of the hypoxia-inducible transcription factor, HIF-2 alpha, in placentas from women with preeclampsia. Biology of Reproduction, 64, 499–506.
Rampersad, R., & Nelson, D. M. (2007). Trophoblast biology, responses to hypoxia and placental dysfunction in preeclampsia. Frontiers in Bioscience, 12, 2447–2456.
Rauch, S., Zender, R., & Kostlin, A. (1956). Biochemistry of placenta extracts. Helv Med Acta, 23, 75–109.
Rinaldo, P., O’Shea, J. J., Coates, P. M., Hale, D. E., Stanley, C. A., & Tanaka, K. (1988). Medium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. New England Journal of Medicine, 319, 1308–1313.
Robinson, C. J., Alanis, M. C., Wagner, C. L., Hollis, B. W., & Johnson, D. D. (2010) Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. American Journal of Obstetrics and Gynecology, 203, 366
Romanowicz, L., & Bankowski, E. (2009). Preeclampsia-associated alterations in sphingolipid composition of the umbilical cord artery. Clinical Biochemistry, 42, 1719–1724.
Schiessl, B., Strasburger, C., Bidlingmaier, M., Mylonas, I., Jeschke, U., Kainer, F., et al. (2006). Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Archives of Gynecology and Obstetrics, 274, 150–154.
Seli, E., Botros, L., Sakkas, D., & Burns, D. H. (2008). Noninvasive metabolomic profiling of embryo culture media using proton nuclear magnetic resonance correlates with reproductive potential of embryos in women undergoing in vitro fertilization. Fertility and Sterility, 90, 2183–2189.
Siskind, L. J. (2005). Mitochondrial ceramide and the induction of apoptosis. Journal of Bioenergetics and Biomembranes, 37, 143–153.
Smith, C. A., Want, E. J., O’Maille, G., Abagyan, R., & Siuzdak, G. (2006). XCMS: processing mass spectrometry data for metabolite profiling using Nonlinear peak alignment, matching, and identification. Analytical Chemistry, 78, 779–787.
Soleymanlou, N., Jurisica, I., Nevo, O., Ietta, F., Zhang, X., Zamudio, S., et al. (2005). Molecular evidence of placental hypoxia in preeclampsia. The journal of clinical endocrinology and metabolism, 90, 4299–4308.
Speake, P. F., Glazier, J. D., Ayuk, P. T., Reade, M., Sibley, C. P., & D’ Souza, S. W. (2003). l-Arginine transport across the basal plasma membrane of the syncytiotrophoblast of the human placenta from normal and preeclamptic pregnancies. Journal of Clinical Endocrinology and Metabolism, 88, 4287–4292.
Spiegel, S., & Milstien, S. (2002). Sphingosine 1-phosphate, a key cell signaling molecule. Journal of Biological Chemistry, 277, 25851–25854.
Tanaka, K., Budd, M. A., Efron, M. L., & Isselbac, K. J. (1966). Isovaleric acidemia—a new genetic defect of leucine metabolism. Proceedings of the National Academy of Sciences of the United States of America, 56, 236.
Tissot van Patot, M. C., Murray, A. J., Beckey, V., Cindrova-Davies, T., Johns, J., Zwerdlinger, L., et al. (2010). Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 298, R166–R172.
Vadillo-Ortega, F., Perichart-Perera, O., Espino, S., Avila-Vergara, M. A., Ibarra, I., Ahued, R., et al. (2011). Effect of supplementation during pregnancy with l-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ, 342, d2901.
Vaiman, D., Mondon, F., Garces-Duran, A.G., Mignot, T.M., Robert, B., Rebourcet, R., et al. (2005). Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in intra-uterine growth retardation. BMC Genomics, 6, 111.
Webster, R. P., Roberts, V. H., & Myatt, L. (2008). Protein nitration in placenta—functional significance. Placenta, 29, 985–994.
Whitridge Williams, J. (2001). Physiology of pregnancy. In F. G. Cunningham, N. F. Gant, K. G. Leveno, L. C. Gilstrap, J. C. Hauth, & K. D. Wenstrom (Eds.), Williams obstetrics (pp. 63–200). New York: McGraw-Hill.
Zelena, E., Dunn, W. B., Broadhurst, D., Francis-McIntyre, S., Carroll, K. M., Begley, P., et al. (2009). Development of a robust and repeatable UPLC–MS method for the long-term metabolomic study of human serum. Analytical Chemistry, 81, 1357–1364.
Zhang, H. H., Wang, Y. P., & Chen, D. B. (2011). Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas. Biology of Reproduction, 84, 966–975.
Acknowledgements
WBD wishes to thank BBSRC for financial support of The Manchester Centre for Integrative Systems Biology (BBC0082191) and the NIHR and NWDA for financial support of CADET. MB wishes to thank Johnson & Johnson for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dunn, W.B., Brown, M., Worton, S.A. et al. The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy. Metabolomics 8, 579–597 (2012). https://doi.org/10.1007/s11306-011-0348-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-011-0348-6